Matches in Wikidata for { <http://www.wikidata.org/entity/Q91298796> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q91298796 description "article scientifique publié en 2018" @default.
- Q91298796 description "artículu científicu espublizáu n'avientu de 2018" @default.
- Q91298796 description "im Dezember 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91298796 description "scientific article published on 01 December 2018" @default.
- Q91298796 description "wetenschappelijk artikel" @default.
- Q91298796 description "наукова стаття, опублікована в грудні 2018" @default.
- Q91298796 name "Capmatinib and gefitinib combination therapy: will EGFR-mutated MET-dysregulated NSCLC "capitulate"?" @default.
- Q91298796 name "Capmatinib and gefitinib combination therapy: will EGFR-mutated MET-dysregulated NSCLC "capitulate"?" @default.
- Q91298796 type Item @default.
- Q91298796 label "Capmatinib and gefitinib combination therapy: will EGFR-mutated MET-dysregulated NSCLC "capitulate"?" @default.
- Q91298796 label "Capmatinib and gefitinib combination therapy: will EGFR-mutated MET-dysregulated NSCLC "capitulate"?" @default.
- Q91298796 prefLabel "Capmatinib and gefitinib combination therapy: will EGFR-mutated MET-dysregulated NSCLC "capitulate"?" @default.
- Q91298796 prefLabel "Capmatinib and gefitinib combination therapy: will EGFR-mutated MET-dysregulated NSCLC "capitulate"?" @default.
- Q91298796 P1433 Q91298796-BBC9F7FA-D5D6-4A67-A036-ADF94E13565D @default.
- Q91298796 P1476 Q91298796-916E41A4-BEE9-461D-BC24-BD61D999ACC4 @default.
- Q91298796 P2093 Q91298796-6D277AE2-0104-4177-B198-1E86A7F36EC0 @default.
- Q91298796 P2093 Q91298796-F1EFF85C-B15D-42F4-AF57-60E43E370976 @default.
- Q91298796 P304 Q91298796-805143C1-7DD2-4364-A2A5-A1AEE3149414 @default.
- Q91298796 P31 Q91298796-463b4338-7df5-4ee3-b2ef-e91a07a91643 @default.
- Q91298796 P31 Q91298796-D5DB13BD-B1C5-45A7-A110-E25D50FB1886 @default.
- Q91298796 P356 Q91298796-2C640647-2C0C-45C1-9CD1-BE73145A7688 @default.
- Q91298796 P433 Q91298796-15C10262-2577-40B6-B8CF-B66F3EDE9A05 @default.
- Q91298796 P478 Q91298796-547BEA97-BCE6-4265-9C48-2DFBA77A05F1 @default.
- Q91298796 P577 Q91298796-29029FFF-EDCE-4D39-8A85-CB1DD404B664 @default.
- Q91298796 P698 Q91298796-64139CEB-7B7B-4D11-828A-4F2C7EC06528 @default.
- Q91298796 P921 Q91298796-B86A0F13-590F-4C51-9611-F8E17604A284 @default.
- Q91298796 P932 Q91298796-F1D0BF5C-2DFF-46CF-B69F-CAB5A213DDEA @default.
- Q91298796 P356 TLCR.2018.12.05 @default.
- Q91298796 P698 30705845 @default.
- Q91298796 P1433 Q26842616 @default.
- Q91298796 P1476 "Capmatinib and gefitinib combination therapy: will EGFR-mutated MET-dysregulated NSCLC "capitulate"?" @default.
- Q91298796 P2093 "Balazs Halmos" @default.
- Q91298796 P2093 "Brian Ko" @default.
- Q91298796 P304 "S321-S325" @default.
- Q91298796 P31 Q13442814 @default.
- Q91298796 P31 Q871232 @default.
- Q91298796 P356 "10.21037/TLCR.2018.12.05" @default.
- Q91298796 P433 "Suppl 4" @default.
- Q91298796 P478 "7" @default.
- Q91298796 P577 "2018-12-01T00:00:00Z" @default.
- Q91298796 P698 "30705845" @default.
- Q91298796 P921 Q3658562 @default.
- Q91298796 P932 "6328688" @default.